clinical trial · NCT07241546
Study of Inhaled ARO-RAGE in Allergen-induced Mild Asthma
AsthmaARO-RAGEPlacebo
brief summary
The purpose of this study is to evaluate the impact of inhaled ARO-RAGE on the late asthmatic response (LAR) following an inhaled allergen challenge in participants with mild atopic asthma.
started
Mar 30, 2026
primary completion
Dec 1, 2027
completion
Apr 1, 2028
last updated
Apr 13, 2026
official title
A Randomized, Double-blind, Placebo-controlled Phase 2a Study of ARO-RAGE Inhalation Solution to Assess Efficacy on Small Airway Dysfunction in Allergen-induced Mild Asthma
sourced from ClinicalTrials.gov · pharmadog mirrors structured fields, not the full protocol